Idiopathic pulmonary fibrosis and cyclosporine: a lesson from single-lung transplantation.

Lok, S S; Smith, E; Doran, H M; Sawyer, R; Yonan, N; Egan, J J · Chest · 1998

case_report · Level V

Where this comes from

Abstract

Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and therapeutic options are limited with a 5-year survival of less than 50%. This report includes a case of histologically confirmed IPF in a patient whose native lung showed objective improvement as measured by high-resolution CT while he was receiving cyclosporine-based immunosuppressive therapy after single-lung transplantation.

Medical subject headings